Skip to main content
OpenTrials

Clinical trial condition

Hematopoietic and Lymphoid System Neoplasm

Explore clinical trials studying Hematopoietic and Lymphoid System Neoplasm. Study availability and eligibility vary by location and protocol.

45 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Hematopoietic and Lymphoid System Neoplasm trial results

Active, Not Recruiting

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

NCT04977024

Conditions
Blood Protein Disorders, COVID-19, COVID-19 Infection, +30 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • U Mass Chan Medical School Worcester, Massachusetts, United States
  • SUNY-Stony Brook Stony Brook, New York, United States
View Trial Details
Active, Not Recruiting

Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

NCT04572815

Conditions
Hematologic Diseases, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid System Neoplasm, +1 more
Locations
  • City of Hope Comprehensive Cancer Center, Duarte, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions